Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS002 in Homozygous Familial Hypercholesterolemia (Phase II, China)
CTR20200378Phase 2Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ongericimab in familial hypercholesterolemia (FH), sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Mar 2020; status: completed.
02
Drugs
ongericimab
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on CTR20200378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200378.